key: cord-0049850-z8tb0rj0
authors: Tran, Nam; Whitman, Jeffrey
title: Molecular microbiology
date: 2020-09-11
journal: Self-Assessment Q&A in Clinical Laboratory Science, III
DOI: 10.1016/b978-0-12-822093-1.00022-3
sha: 52bcd1873dbcfa741e8d6e653c72284fd4dedff4
doc_id: 49850
cord_uid: z8tb0rj0

nan

1. An elderly patient presenting to the Emergency Department with respiratory symptoms was screened using a point-of-care (POC) molecular influenza A/B and respiratory syncytial virus (RSV) assay. He indicated symptom onset was two days ago. Results showed the patient was influenza A positive, and influenza B and RSV negative. The patient was started on oseltamivir, admitted for observation due to being in a higher risk category, and placed under isolation precautions. The Infectious Disease service ordered a subsequent multiplex respiratory panel three days later to determine if the patient can be released from isolation. Results came back as rhinovirus positive and influenza A/B negative. The Infectious Disease service was concerned the POC result was a false positive. The Molecular Laboratory reran the patient sample collected from the third day and showed rhinovirus positive, influenza A positive, and influenza B negative. What is the likely reason for the discordant results? a. Oseltamivir therapy reduced viral nucleic acid loads at or near the limit of detection. b. Incorrect patient for the POC test. c. Rhinovirus RNA interfering with the influenza probes for the multiplex respiratory pathogen panel. d. The patient contracted rhinovirus in the hospital. e. Environmental contamination of the PCR sample.

A patient with a suspected Staphylococcus aureus skin and soft tissue infection was admitted to the Emergency Department. Wound swabs were collected for microbiological culture and paired with a rapid polymerase chain reaction (PCR) assay performed at the point of care. The PCR assay has the ability to differentiate between methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA). PCR reported MSSA and the patient was prescribed antibiotics (nafcillin). Two days later, the patient presents with worsening signs of infection and previous microbiological culture results report MRSA and requiring a treatment change to vancomycin therapy to target the pathogen. What is the likely cause of the discrepant PCR result? a. The pathogen was a variant or did not contain the mecA gene for methicillin resistant despite presenting phenotypically MRSA. b. MRSA concentrations were below the detection limit of the PCR test and picked up the more common MSSA microbe. c. The PCR reagents failed to amplify the mecA gene causing an incorrect MSSA result. d. An interfering substance on the skin inhibited the detection of MRSA by PCR. e. none of the above 3. Point-of-care molecular Group A Streptococcus (GAS) assays are now commercially available as a CLIA-waived test. In contrast to rapid antigen tests for GAS, negative molecular results should be followed by: a. microbiological culture to confirm results b. empiric antimicrobial therapy targeting GAS c. no antimicrobial therapy targeting GAS d. confirmatory molecular testing for GAS e. none of the above. b. Reverse transcriptase is required for GAS PCR assays. c. Taq polymerase is required for influenza A PCR assays. d. Taq polymerase is required for GAS PCR assays. e. Thermocycling is required for GAS due to the circular genome.

13. In 2009 the H1N1 "swine flu" pandemic revealed certain rapid antigen tests were not able to detect the variant pathogen. However, molecular assays were able to detect this H1N1 variant. What is the likely reason for this discrepancy between immunoassays vs molecular tests? 

APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhea in female urine and endocervical swab specimens

Molecular diagnosis of bacterial vaginosis: an update

Group B streptococcus is the most common cause of meningitis in neonates-accounting for 66% of meningitis events in the first three months of life in the United States. Phares CR, et al. Epidemiology of invasive group B streptococcal disease in the United States

Covid-19 is a member of the corona family of RNA viruses. The preferred specimen is a nsasal or throat swab, and the preferred methodology is RT-PCR

CDC recommendations for availability of laboratory testing for STDs include NAAT for the following infectious diseases: Chlamydia trachomatis and Neisseria gonorrhea (urogenital and extragenital), HPV (with Pap smear), and HSV (viral culture is an acceptable NAAT substitute). Availability of serological testing is recommended for hepatitis A, B, and C, HIV (4th generation antigen/antibody), syphilis, and HSV

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services

PCR) is recommended for enterovirus, HSV-1/2, VZV. Immunoassay testing for syphilis and cryptococcal antigen (D and E) is routinely done in CSF, but is not NAAT as the question asked. Venkatesan A et al. Diagnosis and management of acute encephalitis: a practical approach

Management of Drug-Resistant Tuberculosis. In Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis

The major mediator of rifampicin resistance in MTB infection is rpoB mutations, which encode the B-subunit of RNA polymerase (b.). Fluoroquinolone resistance is caused by mutations in gyrA/gyrB encoding DNA gyrase (d.). Amikacin/kanamycin resistance can be seen with mutations in rrs, which encodes 16S rRNA (e.). Almeida Da Silva PE, et al. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs

Clostridium difficile can be broken down into toxigenic (toxin A-or B-producing) and nontoxigenic strains. Studies have shown healthy adults can be carriers of nontoxigenic strains

Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

One infection that does benefit from NAAT is trichomoniasis, caused by Trichomonas vaginalis; a sexually transmitted parasite that most commonly infects the urogenital track of men and women. Symptoms of infection can include irritation, itching or burning, and discharge. NAAT in urogenital swabs and urine has shown superior sensitivity and specificity and is currently the recommended method for screening by the CDC. Barrow RY, et al. Recommendations for providing quality sexually transmitted diseases clinical services